Evaluation & the Health Professions

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click Here for More Information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, G. L.
Right arrow Articles by Edwards, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, G. L.
Right arrow Articles by Edwards, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Evaluation & the Health Professions, Vol. 29, No. 4, 355-366 (2006)
DOI: 10.1177/0163278706296003

Follow-Up for Medical Care Among Drug Users With Hepatitis C

Grace L. Reynolds

Dennis G. Fisher

California State University, Long Beach

Adi Jaffe

University of California, Los Angeles

Jordan Edwards

California State University, Long Beach

Prevalence of hepatitis C (HCV) in injection drug users (IDUs) is high and once HCV has been detected, follow-up medical care is essential. Six hundred and one current and former IDUs who tested positive for HCV antibodies received referrals for medical care. Twenty-four percent (147) of participants returned to be interviewed regarding their medical follow-ups. Of these, only 42% (61) had sought additional medical care in the form of further liver or blood tests or liver ultrasound. Four variables predicted seeking medical care: (a) ever being in residential drug treatment, (b) ever trading sex for money, (c) self-reported homelessness, and (d) living in one's own apartment or house. Having income from a job was inversely associated with seeking medical care. Knowledge of HCV infection alone does not mean that IDUs will seek medical care. Additional education concerning medical care and treatment options are needed to address IDU needs.

Key Words: hepatitis C • injection drug users and medical care • referrals

References

  • Alter, M. J. (1997). Epidemiology of hepatitis C. Hepatology, 26, 62S-65S.[CrossRef][Medline] [Order article via Infotrieve]
  • Butt, A. A., Wagener, M., Shakil, A. O., & Ahmad, J. (2005). Reasons for non-treatment of hepatitis C in veterans in care. Journal of Viral Hepatitis, 12, 81-85.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Cagle, H. H., Fisher, D. G., Senter, T. P., Thurmond, R. D., & Kastar, A. J. (2002). Classifying skin lesions of injection drug users: A method for corroborating disease risk(Inventory Number AVD154). Rockville, MD: Substance Abuse and Mental Health Services Administration, National Clearinghouse for Alcohol and Drug Information. Retrieved from www.samhsa.gov/centers/clearinghouse/clearinghouses.html
  • Des Jarlais, D. C., Fisher, D. G., Newman, J. C., Trubatch, B. N., Yancovitz, M., Paone, D., et al. (2001). Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs. on-site vaccination at a syringe exchange program. American Journal of Public Health, 91(11), 1791-1792.[Free Full Text]
  • Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Anderson, M., et al. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of selfreported recent drug use. Assessment, 1(4), 383-392.
  • Edlin, B. R., Kresina, T. F., Raymond, D. B., Carden, M. R., Gourevitch, M. N., Rich, J. D., et al. (2005). Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Disease, 40(Suppl. 5), S276-S285.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Fireman, M., Indest, D. W., Blackwell, A. D., Whitehead, A. J., & Hauser, P. (2005). Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a co-management model of care. Clinical Infectious Disease, 40(Suppl. 5), S286-S291.[Medline] [Order article via Infotrieve]
  • Fishbein, D. A., Lo, Y., Reinus, J. F., Gourevitch, M. N., & Klein, R. S. (2004). Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes, 37(3), 1367-1375.[Medline] [Order article via Infotrieve]
  • Fisher, D. G., Fenaughty, A. M., Paschane, A. A., Paschane, D. M., Cagle, H. H., & Orr, S. M. (1997). Hepatitis C virus among Alaskan drug users. American Journal of Public Health, 87(10), 1722-1724.[Free Full Text]
  • Fisher, D. G., Reynolds, G. L., Jaffe, A., & Perez, M. J. (2006). Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California. Journal of Addictive Diseases, 25(2), 25-32.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Fry, C. L., & Lintzeris, N. (2003). Psychometric properties of the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction, 98, 171-178.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Fultz, S. L., Justice, A. C., Butt, A. A., Rabeneck, L., Weissman, S., Rodriguez-Barradas, M., et al. (2003). Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clinical Infectious Disease, 36, 1039-1046.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes, 18(Suppl. 1), S11-S19.
  • Giordano, T. P., Visnegarwala, F., White, A. C. J., Troisi, C. L., Frankowski, R. F., Hartman, C. M., et al. (2005). Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care, 17(6), 773-783.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Hagan, H., Thiede, H., & Des Jarlais, D. C. (2005). HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS, 19(Suppl. 3), S199-S207.[Medline] [Order article via Infotrieve]
  • Huckans, M. S., Blackwell, A. D., Harms, T. A., Indest, D. W., & Hauser, P. (2005). Integrated hepatitis C virus treatment: Addressing co-morbid substance use disorders and HIV infection. AIDS, 19(Suppl 3), S106-S115.[Medline] [Order article via Infotrieve]
  • Johnson, M. E., Fisher, D. G., Fenaughty, A. M., & Theno, S. A. (1998). Hepatitis C virus and depression in drug users. American Journal of Gastroenterology, 93(5), 785-789.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kim, W. R. (2002). The burden of hepatitis C in the United States. Hepatology, 36(5, Suppl. 1), S30-S34.[ISI][Medline] [Order article via Infotrieve]
  • Kresina, T. F., Bruce, R. D., Cargill, V. A., & Cheever, L. W. (2005). Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users co-infected with HIV and HCV. Clinical Infectious Disease, 41(Suppl. 1), S83-S88.[Medline] [Order article via Infotrieve]
  • Mehta, S. H., Thomas, D. L., Sulkowski, M. S., Safaein, M., Vlahov, D., & Strathdee, S. A. (2005). A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS, 19(Suppl. 3), S179-S189.[Medline] [Order article via Infotrieve]
  • Needle, R., Weatherby, N., Chitwood, D., Booth, R., Watters, J., Fisher, D. G., et al. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9(4), 242-250.[CrossRef][ISI]
  • Pollio, D. E., Sptznagel, E. L., North, C. S., Thompson, S., & Foster, D. A. (2000). Service use over time and achievement of stable housing in a mentally ill homeless population. Psychiatric Services, 51(12), 1536-1543.[Abstract/Free Full Text]
  • Stein, M. D., Maksad, J., & Clarke, J. (2001). Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence, 61, 211-215.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Stoove, M. A., Gifford, S. M., & Dore, G. J. (2005). The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence, 77(1), 81-86.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Strauss, S. M., Falkin, G. P., Vassilev, Z. P., Des Jarlais, D. C., & Astone, J. (2002). A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment, 22, 55-62.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Strauss, S. M., Vassilev, Z. P., & Des Jarlais, D. C. (2003). Provision of hepatitis E education in a nationwide sample of drug treatment programs. Journal of Drug Education, 33(1), 107-117.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Trubatch, B. A., Fisher, D. G., Cagle, H. H., & Fenaughty, A. M. (2000). Vaccination strategies for targeted and difficult-to-access groups. American Journal of Public Health, 90(3).

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Public HealthHome page
C. M. Rousseau, G. N. Ioannou, J. A. Todd-Stenberg, K. L. Sloan, M. F. Larson, C. W. Forsberg, and J. A. Dominitz
Racial Differences in the Evaluation and Treatment of Hepatitis C Among Veterans: A Retrospective Cohort Study
Am J Public Health, May 1, 2008; 98(5): 846 - 852.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, G. L.
Right arrow Articles by Edwards, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, G. L.
Right arrow Articles by Edwards, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?